Pharma Journalist 8932 posts 0 comments

AstraZeneca’s Imfinzi (durvalumab) has been approved in the US for an additional dosing option, a 1,500mg fixed dose every four weeks, in the approved indications of unresectable Stage…
Read More...

Eli Lilly and Company and Incyte announced that the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for the distribution and emergency use of…
Read More...

SMi Reports: There is only one to go to join the online webinar taking place on Thursday 26th November 2020 on Cost-efficient and Green Manufacturing of Peptides thanks to Molecular…
Read More...

Zymeworks Inc. announced that the European Commission (EC) has granted Orphan Drug designation for zanidatamab, the company’s investigational HER2-targeted bispecific antibody, in…
Read More...

The U.S. Food and Drug Administration (FDA) has granted Fast Track Designation (FTD) to the oral investigational Bruton’s tyrosine kinase (BTK) inhibitor, rilzabrutinib, which has the…
Read More...

Pfizer Inc. and BioNTech SE announced that, after conducting the final efficacy analysis in their ongoing Phase 3 study, their mRNA-based COVID-19 vaccine candidate, BNT162b2, met all…
Read More...

Samsung Bioepis Co., Ltd. and Biogen Inc. announced that the U.S. Food and Drug Administration (FDA) has accepted for review the Biologics License Application for SB11, a proposed…
Read More...

InMed Pharmaceuticals Inc. a clinical-stage pharmaceutical company developing medications targeting diseases with high unmet medical need and leading the way in the clinical development…
Read More...

ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc, with Pfizer Inc. and Shionogi Limited as shareholders, announced that the US Food and Drug…
Read More...

Moderna, Inc. a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, announced that the…
Read More...